This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blake, N. W.
Right arrow Articles by Wang, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blake, N. W.
Right arrow Articles by Wang, F.

 Previous Article  |  Next Article 

Journal of Virology, September 1999, p. 7381-7389, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Inhibition of Antigen Presentation by the Glycine/Alanine Repeat Domain Is Not Conserved in Simian Homologues of Epstein-Barr Virus Nuclear Antigen 1

Neil W. Blake,1 Amir Moghaddam,2 Pasupuleti Rao,2 Amitinder Kaur,3 Rhona Glickman,3 Young-gyu Cho,2 Andrew Marchini,4 Tracey Haigh,1 R. Paul Johnson,3,5 Alan B. Rickinson,1 and Fred Wang2,*

CRC Institute for Cancer Studies, University of Birmingham Medical School, Edgbaston, Birmingham B15 2TA, United Kingdom1; Department of Immunology, New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts 017723; Partners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital,5 and Department of Medicine, Brigham and Women's Hospital,2 Harvard Medical School, Boston, Massachusetts 02115; and Howard Hughes Medical Institute, Princeton University, Princeton, New Jersey 085444

Received 11 May 1999/Accepted 1 June 1999

Most humans and Old World nonhuman primates are infected for life with Epstein-Barr virus (EBV) or closely related gammaherpesviruses in the same lymphocryptovirus (LCV) subgroup. Several potential strategies for immune evasion and persistence have been proposed based on studies of EBV infection in humans, but it has been difficult to test their actual contribution experimentally. Interest has focused on the EBV nuclear antigen 1 (EBNA1) because of its essential role in the maintenance and replication of the episomal viral genome in latently infected cells and because EBNA1 endogenously expressed in these cells is protected from presentation to the major histocompatibility complex class-I restricted cytotoxic T-lymphocyte (CTL) response through the action of an internal glycine-alanine repeat (GAR). Given the high degree of biologic conservation among LCVs which infect humans and Old World primates, we hypothesized that strategies essential for viral persistence would be well conserved among viruses of this subgroup. We show that the rhesus LCV EBNA1 shares sequence homology with the EBV and baboon LCV EBNA1 and that the rhesus LCV EBNA1 is a functional homologue for EBV EBNA1-dependent plasmid maintenance and replication. Interestingly, all three LCVs possess a GAR domain, but the baboon and rhesus LCV EBNA1 GARs fail to inhibit antigen processing and presentation as determined by using three different in vitro CTL assays. These studies suggest that inhibition of antigen processing and presentation by the EBNA1 GAR may not be an essential mechanism for persistent infection by all LCV and that other mechanisms may be important for immune evasion during LCV infection.


* Corresponding author. Mailing address: Channing Laboratories, 181 Longwood Ave., Boston, MA 02115. Phone: (617) 525-4258. Fax: (617) 525-4257. E-mail: fwang{at}rics.bwh.harvard.edu.


Journal of Virology, September 1999, p. 7381-7389, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Tellam, J., Fogg, M. H., Rist, M., Connolly, G., Tscharke, D., Webb, N., Heslop, L., Wang, F., Khanna, R. (2007). Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes. JEM 204: 525-532 [Abstract] [Full Text]  
  • Fogg, M. H., Kaur, A., Cho, Y.-G., Wang, F. (2005). The CD8+ T-Cell Response to an Epstein-Barr Virus-Related Gammaherpesvirus Infecting Rhesus Macaques Provides Evidence for Immune Evasion by the EBNA-1 Homologue. J. Virol. 79: 12681-12691 [Abstract] [Full Text]  
  • Rivailler, P., Carville, A., Kaur, A., Rao, P., Quink, C., Kutok, J. L., Westmoreland, S., Klumpp, S., Simon, M., Aster, J. C., Wang, F. (2004). Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Blood 104: 1482-1489 [Abstract] [Full Text]  
  • Lee, S. P., Brooks, J. M., Al-Jarrah, H., Thomas, W. A., Haigh, T. A., Taylor, G. S., Humme, S., Schepers, A., Hammerschmidt, W., Yates, J. L., Rickinson, A. B., Blake, N. W. (2004). CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1. JEM 199: 1409-1420 [Abstract] [Full Text]  
  • Rivailler, P., Jiang, H., Cho, Y.-g., Quink, C., Wang, F. (2002). Complete Nucleotide Sequence of the Rhesus Lymphocryptovirus: Genetic Validation for an Epstein-Barr Virus Animal Model. J. Virol. 76: 421-426 [Abstract] [Full Text]  
  • Cho, Y.-G., Ramer, J., Rivailler, P., Quink, C., Garber, R. L., Beier, D. R., Wang, F. (2001). An Epstein-Barr-related herpesvirus from marmoset lymphomas. Proc. Natl. Acad. Sci. USA 98: 1224-1229 [Abstract] [Full Text]  
  • Rao, P., Jiang, H., Wang, F. (2000). Cloning of the Rhesus Lymphocryptovirus Viral Capsid Antigen and Epstein-Barr Virus-Encoded Small RNA Homologues and Use in Diagnosis of Acute and Persistent Infections. J. Clin. Microbiol. 38: 3219-3225 [Abstract] [Full Text]  
  • Dantuma, N. P., Heessen, S., Lindsten, K., Jellne, M., Masucci, M. G. (2000). Inhibition of proteasomal degradation by the Gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal. Proc. Natl. Acad. Sci. USA 10.1073/pnas.140217397v1 [Abstract] [Full Text]  
  • Jiang, H., Cho, Y.-g., Wang, F. (2000). Structural, Functional, and Genetic Comparisons of Epstein-Barr Virus Nuclear Antigen 3A, 3B, and 3C Homologues Encoded by the Rhesus Lymphocryptovirus. J. Virol. 74: 5921-5932 [Abstract] [Full Text]  
  • Alexander, L., Denekamp, L., Knapp, A., Auerbach, M. R., Damania, B., Desrosiers, R. C. (2000). The Primary Sequence of Rhesus Monkey Rhadinovirus Isolate 26-95: Sequence Similarities to Kaposi's Sarcoma-Associated Herpesvirus and Rhesus Monkey Rhadinovirus Isolate 17577. J. Virol. 74: 3388-3398 [Abstract] [Full Text]  
  • Cho, Y.-G., Gordadze, A. V., Ling, P. D., Wang, F. (1999). Evolution of Two Types of Rhesus Lymphocryptovirus Similar to Type 1 and Type 2 Epstein-Barr Virus. J. Virol. 73: 9206-9212 [Abstract] [Full Text]  
  • Rivailler, P., Quink, C., Wang, F. (1999). Strong Selective Pressure for Evolution of an Epstein-Barr Virus LMP2B Homologue in the Rhesus Lymphocryptovirus. J. Virol. 73: 8867-8872 [Abstract] [Full Text]  
  • Dantuma, N. P., Heessen, S., Lindsten, K., Jellne, M., Masucci, M. G. (2000). Inhibition of proteasomal degradation by the Gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal. Proc. Natl. Acad. Sci. USA 97: 8381-8385 [Abstract] [Full Text]